Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 14.90
-0.35 (-2.30%)
At close: Dec 5, 2025
Acepodia Market Cap
Acepodia has a market cap or net worth of 8.66 billion as of December 5, 2025. Its market cap has decreased by -16.04% in one year.
Market Cap
8.66B
Enterprise Value
3.82B
Revenue
301.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
14.90
Market Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 8.66B, a decrease of -62.21%. That is a compound annual growth rate of -34.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 8.66B | -13.16% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
| Aug 8, 2023 | 22.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 283.81B |
| PharmaEssentia | 191.21B |
| Lotus Pharmaceutical | 78.37B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Oneness Biotech | 33.97B |
| Lin BioScience | 33.46B |
| Lumosa Therapeutics | 32.68B |
| Center Laboratories | 28.03B |